Logo image of CHG.DE

CHAPTERS GROUP AG (CHG.DE) Stock Fundamental Analysis

FRA:CHG - Deutsche Boerse Ag - DE0006618309 - Common Stock - Currency: EUR

45.6  +2.6 (+6.05%)

Fundamental Rating

3

Overall CHG gets a fundamental rating of 3 out of 10. We evaluated CHG against 47 industry peers in the Financial Services industry. While CHG seems to be doing ok healthwise, there are quite some concerns on its profitability. CHG shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CHG had negative earnings in the past year.
CHG had a positive operating cash flow in the past year.
In multiple years CHG reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CHG reported negative operating cash flow in multiple years.
CHG.DE Yearly Net Income VS EBIT VS OCF VS FCFCHG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

1.2 Ratios

The Return On Assets of CHG (-3.46%) is worse than 85.11% of its industry peers.
The Return On Equity of CHG (-5.46%) is worse than 82.98% of its industry peers.
Industry RankSector Rank
ROA -3.46%
ROE -5.46%
ROIC N/A
ROA(3y)-3.47%
ROA(5y)-1.12%
ROE(3y)-5.22%
ROE(5y)-0.89%
ROIC(3y)N/A
ROIC(5y)N/A
CHG.DE Yearly ROA, ROE, ROICCHG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

With a decent Gross Margin value of 81.23%, CHG is doing good in the industry, outperforming 74.47% of the companies in the same industry.
In the last couple of years the Gross Margin of CHG has declined.
The Profit Margin and Operating Margin are not available for CHG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-4.07%
CHG.DE Yearly Profit, Operating, Gross MarginsCHG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20K -20K 40K -40K 60K

4

2. Health

2.1 Basic Checks

CHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CHG has been increased compared to 1 year ago.
Compared to 5 years ago, CHG has more shares outstanding
CHG has a better debt/assets ratio than last year.
CHG.DE Yearly Shares OutstandingCHG.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CHG.DE Yearly Total Debt VS Total AssetsCHG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 4.77 indicates that CHG is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.77, CHG is in the better half of the industry, outperforming 76.60% of the companies in the same industry.
CHG has a debt to FCF ratio of 4.06. This is a neutral value as CHG would need 4.06 years to pay back of all of its debts.
The Debt to FCF ratio of CHG (4.06) is better than 74.47% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that CHG is not too dependend on debt financing.
CHG's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. CHG outperforms 78.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 4.06
Altman-Z 4.77
ROIC/WACCN/A
WACC6.98%
CHG.DE Yearly LT Debt VS Equity VS FCFCHG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.97 indicates that CHG may have some problems paying its short term obligations.
CHG has a Current ratio of 0.97. This is in the lower half of the industry: CHG underperforms 68.09% of its industry peers.
CHG has a Quick Ratio of 0.97. This is a bad value and indicates that CHG is not financially healthy enough and could expect problems in meeting its short term obligations.
CHG's Quick ratio of 0.92 is on the low side compared to the rest of the industry. CHG is outperformed by 63.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.92
CHG.DE Yearly Current Assets VS Current LiabilitesCHG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

7

3. Growth

3.1 Past

CHG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.47%.
Looking at the last year, CHG shows a very strong growth in Revenue. The Revenue has grown by 56.39%.
CHG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 308.75% yearly.
EPS 1Y (TTM)-48.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-116.32%
Revenue 1Y (TTM)56.39%
Revenue growth 3Y3228.95%
Revenue growth 5Y308.75%
Sales Q2Q%63.43%

3.2 Future

The Earnings Per Share is expected to grow by 94.37% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.27% on average over the next years. This is a very strong growth
EPS Next Y116.67%
EPS Next 2Y94.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year30.01%
Revenue Next 2Y22.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CHG.DE Yearly Revenue VS EstimatesCHG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
CHG.DE Yearly EPS VS EstimatesCHG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CHG. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 57.88 indicates a quite expensive valuation of CHG.
CHG's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CHG is more expensive than 74.47% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.67, CHG is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 57.88
CHG.DE Price Earnings VS Forward Price EarningsCHG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHG indicates a slightly more expensive valuation: CHG is more expensive than 70.21% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CHG is valued a bit more expensive than the industry average as 65.96% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 73.13
EV/EBITDA 101.88
CHG.DE Per share dataCHG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

CHG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CHG's earnings are expected to grow with 94.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y94.37%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CHG!.
Industry RankSector Rank
Dividend Yield N/A

CHAPTERS GROUP AG

FRA:CHG (7/28/2025, 4:28:00 PM)

45.6

+2.6 (+6.05%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-22 2025-05-22
Earnings (Next)N/A N/A
Inst Owners6.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.07B
Analysts80
Price Target49.98 (9.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)36.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 57.88
P/S 9.67
P/FCF 73.13
P/OCF 55.91
P/B 4.77
P/tB 63.28
EV/EBITDA 101.88
EPS(TTM)-0.54
EYN/A
EPS(NY)0.79
Fwd EY1.73%
FCF(TTM)0.62
FCFY1.37%
OCF(TTM)0.82
OCFY1.79%
SpS4.72
BVpS9.57
TBVpS0.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.46%
ROE -5.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.23%
FCFM 13.22%
ROA(3y)-3.47%
ROA(5y)-1.12%
ROE(3y)-5.22%
ROE(5y)-0.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-4.07%
F-Score4
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 4.06
Debt/EBITDA 1.64
Cap/Depr 22.14%
Cap/Sales 4.07%
Interest Coverage N/A
Cash Conversion 196.18%
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.92
Altman-Z 4.77
F-Score4
WACC6.98%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-116.32%
EPS Next Y116.67%
EPS Next 2Y94.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)56.39%
Revenue growth 3Y3228.95%
Revenue growth 5Y308.75%
Sales Q2Q%63.43%
Revenue Next Year30.01%
Revenue Next 2Y22.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-106.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year162.04%
EBIT Next 3Y54.75%
EBIT Next 5Y59.64%
FCF growth 1Y59.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.05%
OCF growth 3YN/A
OCF growth 5YN/A